Sandy Cove Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Sandy Cove Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-358	Closed	-$208K	–	153
2025 Q4	$208K	Buy	+358	New	+$202K	0.06%	139
2025 Q1	–	Sell	-427	Closed	-$222K	–	129
2024 Q4	$222K	Sell	427 -2	-0.5%	-$1.1K	0.09%	117
2024 Q3	$265K	Hold	429	–	–	0.11%	104
2024 Q2	$237K	Sell	429 -32	-7%	-$18.3K	0.11%	103
2024 Q1	$268K	Sell	461 -10	-2%	-$5.61K	0.12%	104
2023 Q4	$250K	Buy	471 +75	+19%	+$36.3K	0.13%	104
2023 Q3	$200K	Sell	396 -33	-8%	-$17.6K	0.12%	112
2023 Q2	$224K	Buy	429 +63	+17%	+$34K	0.13%	111
2023 Q1	$211K	Sell	366 -27	-7%	-$15.2K	0.15%	84
2022 Q4	$216K	Buy	+393	New	+$208K	0.17%	69
2022 Q2	–	Sell	-293	Closed	-$173K	–	352
2022 Q1	$173K	Sell	293 -9	-3%	-$5.17K	0.14%	94
2021 Q4	$202K	Buy	+302	New	+$189K	0.17%	78

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sandy Cove Advisors's TMO Position: Q1 2026 in Review

Sandy Cove Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 358 shares — an estimated $208K sold.

Sandy Cove Advisors first reported a position in TMO in Q4 2021 and held it in 12 quarters. The position peaked at $268K in Q1 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Sandy Cove Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Sandy Cove Advisors sold 358 Thermo Fisher Scientific shares in Q1 2026, an estimated $208K.
Sandy Cove Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 12 quarters.
Sandy Cove Advisors's Thermo Fisher Scientific position peaked at $268K in Q1 2024.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Sandy Cove Advisors's 13F filing for Q1 2026, filed 5 May 2026.